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Introduction
Together, the world’s eight acknowl-
edged nuclear powers—the United States
(US), Russia, United Kingdom (UK),
France, China, India, Pakistan, and the
Democratic People’s Republic of Korea
(North Korea)—have amassed an arsenal
of almost 30,000 nuclear weapons since
1945. In addition, Israel is believed to be a
nuclear power while Iran (and possibly
Syria as well) is alsosuspectedof developing
nuclear weapons. Despite the technological
sophistication that has enabled the 11
nuclear weapons states to produce and
deliver nuclear bombs, most of these
nations simultaneously also suffer from
high internal rates of poverty and endemic
neglected diseases. They include high
prevalence rates of neglected tropical
diseases in India, China, Pakistan, Iran,
and Syria, and related neglected infections
of poverty in the US and Europe. Indeed,
the 11 nuclear weapons states together
account for up to one-half of the global
disease burden from all neglected diseases.
However, for a tiny fraction (less than
1/10,000
th) of the costs of producing and
maintaining a nuclear arsenal the 11
nuclear powers could eliminate most of
their neglected diseases and engage in joint
neglected disease research and develop-
ment efforts that help to reduce interna-
tional tensions and promote world peace.
Shown in Table 1 and Figure 1 are the
11 established and suspected global nucle-
ar powers. Following the development and
deployment of the atomic bomb by the US
in 1945 (at an estimated cost of US$20
billion), Russia became the second nuclear
power in 1949, and in every decade since
then at least one new country has joined
the nuclear club [1,2]. In addition three
countries, South Africa, Argentina, and
Brazil, began active nuclear weapons
programs, but subsequently abandoned
them by mutual treaty [1]. Today, only
the first five nations to produce nuclear
weapons,,the US, Russia, UK, France,
and China, have signed the nuclear
nonproliferation treaty [1]. The costs to
maintain these nuclear arsenals are stag-
gering. According to the Brookings Insti-
tution, which in 1998 published their US
Nuclear Weapons Cost Study Project, the
US alone spent $35 billion that year on
nuclear weapons technology [2]. Further
estimates indicate that the US may have
spent more than $5.5 trillion in developing
their nuclear arsenal, while France has
invested approximately $1.5 trillion [3].
Although the data are unavailable, the
costs for other nuclear weapon states are
believed to be similar [3]. Therefore it is
likely that the 11 nuclear weapons states
together have invested at least $10 trillion
on weapons production and maintenance.
Despite this massive expenditure, each
of the 11 nuclear weapons states, with the
possible exception of the U.K., also suffers
from high rates of neglected tropical
diseases (and related neglected infections
of poverty), defined as chronic and debil-
itating parasitic and other infectious dis-
eases that occur in association with
extreme poverty [4]. In addition to their
health effects, the neglected tropical dis-
eases also cause poverty through their
ability to impair child physical and
intellectual development, pregnancy out-
comes, and worker productivity, while
simultaneously promoting conflict and
war through their agriculturally and so-
cially destabilizing effects [4,5]. Although
it is common to think of neglected diseases
as confined to low-income countries in
sub-Saharan Africa, Southeast Asia, and
Latin America, as shown in Table 2 these
infections also exhibit a high prevalence in
middle-income countries such as China,
India, Pakistan, North Korea, Iran, and
Syria, as well as in selected areas of
poverty found in the US, Russia, and
Eastern Europe [6]. Indeed, with the
possible exceptions of the UK, high
neglected disease burdens are present in
all of the nuclear weapons states, particu-
larly the helminth infections, leishmaniasis
and Chagas disease, toxoplasmosis, and
trachoma.
Helminthic Neglected Infections
The four major soil-transmitted hel-
minth infections of humans include ascari-
asis (roundworm), trichuriasis (whipworm),
hookworm infection, and strongyloidiasis
(threadworm) [7]. These intestinal worm
infections represent the most common
neglected tropical diseases of humans living
in poverty [7,8]. Of the estimated 800
million ascariasis infections found predom-
inantly in low- and middle-income coun-
tries [7], approximately one-third of the
cases occur in nuclear weapons states
including India (140 million), China (86
million), North Korea (8 million), Pakistan
(7 million), and Iran (5 million) [8,9]. These
nations also account for 20% of the world’s
cases of hookworm infection, which is
associated with anemia and extreme pov-
erty resulting from impairments in child
development and cognition, maternal mor-
bidity during pregnancy, and diminished
agricultural worker productivity [4,7,8,9].
Trichuriasis and strongyloidiasis are en-
demictothesecountriesaswell,andthe US
and France have pockets of endemic
strongyloidiasis in, respectively, Appalachia
and in Region Midi-Pyrenees in the
Southwest [10,11]. In the US and else-
where, toxocariasis is a soil-transmitted
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migrans syndromes, asthma, and develop-
mental delays in up to 3 million African
Americans living in poverty [10].
India accounts for roughly one-quarter
of the world’s 120 million cases of
lymphatic filariasis, a disfiguring and
stigmatizing vector-borne infection associ-
ated with elephantiasis [12], while China
accounts for most of the world’s food-
borne trematode infections, including 13
million cases of clonorchiasis (liver fluke
infection associated with liver fibrosis and
bile duct cancer) and paragonimiasis (lung
fluke infection associated with hemoptysis
and other pulmonary disorders) [9,13,14].
Clonorchiasis is also endemic to North
Korea [15], while a related liver fluke
infection known as opisthorchiasis is highly
endemic to Russia where an estimated
12.5 million people are at risk of infection,
and in some parts of Siberia up to 95% of
the population is infected [13,16]. Up to
169,000 cases of cysticercosis occur among
Hispanic Americans in the US [10].
Leishmaniasis and Other
Protozoan Neglected Infections
Leishmaniasis is a serious sandfly-trans-
mitted neglected tropical disease endemic
to the Asian and Middle Eastern nuclear
states where it is associated with extreme
poverty [4,17]. The visceral form (caused
by Leishmania donovani in Asia and the
Middle East) is the most severe and is
associated with profound pancytopenia,
hepatosplenomegaly, and failure to thrive
when it occurs in childhood. Annually,
there are approximately 500,000 new
cases of visceral leishmaniasis worldwide
with more than one-half of these cases
(270,000) occurring in India alone [17].
Most of the Indian cases occur in the
impoverished state of Bihar [17], while in
Pakistan visceral leishmaniasis is endemic
to Azad Jammu and Kashmir, on the
Indian border [18]. Visceral leishmaniasis
is also endemic to Iran and Syria [19,20],
and it occurs in southern France where it
is a zoonosis caused by L. infantum with
dogs as the major animal reservior, and
recognized as an opportunistic infection
with patients with HIV/AIDS [21,22]. In
most of the countries where visceral
leishmaniasis is found [22–26], including
Israel [27], the cutaneous form is also
present and caused by either L. major or L.
tropica. Cutaneous leishmaniasis is disfigur-
ing and highly stigmatizing, especially for
young women [4]. In the US, cutaneous
leishmaniasis caused by L. mexicana and
possibly other species has emerged along
the border with Mexico [10]. Up to one
million cases of Chagas disease are found
in the US as well, mostly among Hispanic
American immigrants, but there is also
evidence of Chagas disease transmission
within the borders of the US [10]. Chagas
disease is also found in France [28].
Toxoplasmosis is an important congenital
protozoan infection that results in blind-
ness and profound mental disabilities
found in all of the nuclear weapons states,
but especially the US and France [29].
Bacterial Neglected Diseases
Almost one-half of the world’s 60–80
million trachoma cases occur in nuclear
weapons states, with China having the
highest number of cases of any nation [30].
Similarly, India has the highest number of
leprosy cases, with more than one-half of the
new infections that occur annually in the
world [31]. Following the collapse of the
former Soviet Union in 1991, as a result of
the disintegration of the state-run health
Figure 1. Map of countries with nuclear weapons. NPT, nuclear nonproliferation treaty.
Source: http://commons.wikimedia.org/wiki/File:Nuclear_weapons.png.
doi:10.1371/journal.pntd.0000680.g001
Table 1. Estimated number of nuclear weapons by Country, 1945–2008.
Country Estimated number of nuclear weapons Date first test conducted Member of Nuclear Non-Proliferation Treaty?
United States 10,000 1945 Yes
USSR/Russia 16,000 1949 Yes
United Kingdom 200 1952 Yes
France 350 1960 Yes
China 410 1964 Yes
India 75–110 1974 No
Israel 100–200 1979? No
Pakistan 60 1998 No
DPR Korea
(North Korea)
,10 2006 No
Iran Suspected nuclear weapons state Not determined No
Syria Suspected nuclear weapons state Not determined No
Sources: [1] and http://en.wikipedia.org/wiki/List_of_states_with_nuclear_weapons.
doi:10.1371/journal.pntd.0000680.t001
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economic changes, the rate of congenital
syphilis rose at a rate 34 times higher than
was seen in Western Europe [32].
Summary of Neglected Diseases
in Nuclear Weapons States
Although the world’s nuclear states
have up to one-third of the world’s cases
of soil-transmitted helminth infections,
more than one-half of the world’s new
cases of leishmaniasis and leprosy, and
approximately one-half of the global
disease burden of trachoma, they have
chosen to devote their major resources to
weapons production instead of neglected
disease control [33]. For example, India
allocates only $0.40 per individual per year
for treatment of its population at risk for
visceral leishmaniasis [17], while the
projected US government annual budget
in 2010 for global neglected tropical
disease control is expected to be $65
million (part of a larger $350 million
U.S. commitment), roughly 1,000 times
less than its annual nuclear weapons
budget [34]. The UK government has
committed approximately £50 million to
neglected tropical disease control [35]. A
distinction can be made between states
that can afford more nuclear weapons (i.e.,
US, UK, France) and those for which
social spending must be curtailed to
pursue nuclear ambitions (i.e., India,
Pakistan, China). In terms of research
and development (R&D) funding the
George Institute estimates that the global
budget for neglected tropical diseases is
approximately $400 million including only
$125 million for leishmaniasis and try-
panosome infections, $80 million for
dengue, $50 million for all helminth
infections, and less than $10 million each
for trachoma, leprosy and Buruli ulcer,
trachoma, and typhoid/paratyphoid [36].
Together, all of the costs for both
neglected disease control and R&D come
close to $1 billion, or roughly less than 1/
10,000
th of the estimated $10 trillion
committed for nuclear weapons.
While some may argue that the trillions
of dollars spent on nuclear weapons may
have served as a successful deterrent for an
all-out US-Soviet, a Sino-Soviet, or an
Indo-Pakistan conflict and was therefore
an actual investment in peace, imagine a
world in which the nuclear weapons states
increased their neglected disease control
budgets more than 10-fold thereby, reduc-
ing the global nuclear weapon–to–neglected
disease gap to 1,000 to 1. Ten billion
dollars devoted to neglected diseases
Table 2. The major neglected tropical diseases or neglected infection of poverty endemic to countries with nuclear weapons.
Country Neglected infection Neglected infection Neglected infection Neglected infection Neglected infection Reference
(Est. Cases) (Est. Cases) (Est. Cases) (Est. Cases) (Est. Cases)
United States Toxocariasis
1–3 million
Trichomoniasis
1 million
Chagas disease
,1 million
Cysticercosis
,0.2 million
Strongyloidiasis
0.1 million
[10,29]
USSR/
Russia
Toxoplasmosis
Prevalence ND
Opisthorchiasis
12.5 million at risk
Congenital syphilis
Incidence 170/100,000
in 1996
[13,16]
[29,32]
United Kingdom Toxocariasis
Prevalence ND
Toxoplasmosis
Prevalence ND
[29]
France Toxoplasmosis
59%
seroprevalence in
pregnancy
Leishmaniasis
Incidence 0.02–0.19/
100,000
Chagas disease
Prevalence ND
Strongyloidiasis
Prevalence ND
[11,21,22,28]
[29]
China Ascariasis
86 million
Hookworm
39 million
Trichuriasis
29 million
Trachoma
27 million
Paragonimiasis
Clonorchiasis
13 million
[9,13,14]
[30]
India Ascariasis
140 million
Trichuriasis
73 million
Hookworm
71 million
Lymphatic filariasis
30 million
Trachoma
1 million
Toxoplasmosis
12–45%
seroprevalence
In pregnancy
Leishmaniasis
0.3 million
[8,12,17,29]
[30]
Israel Leishmaniasis
Incidence
0.13–7/100,000
[27]
Pakistan Ascariaisis
21 million
Hookworm
2 million
Trichuriasis
1.5 million
Trachoma
0.3 million
Leishmaniasis
Prevalence ND
[8,18,26,30]
DPR Korea
(North Korea)
Ascariasis
8 million
Hookworm
1 million
Trichuriasis
0.2 million
Clonorchiasis
Prevalence ND
[8,15]
Iran Ascariasis
5 million
Trichuriasis
1.6 million
Hookworm
0.4 million
Toxoplasmosis
29–64% seroprevalence
in pregnancy or women
Leishmaniasis
Prevalence ND
Trachoma
15,000
[8,19,24,25,29]
[30]
Syria Leishmaniasis
Prevalence ND
[20,23]
ND, not determined.
doi:10.1371/journal.pntd.0000680.t002
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control or elimination for most of the high-
prevalence neglected tropical diseases in
the 56 nations where five or more of these
conditions are endemic [37–38]. Among
the nuclear weapons states these 56
nations include India and China, although
sufficient funds would remain to tackle
neglected infections among pockets of
poverty in the remaining wealthy nine
nuclear countries. In addition to the
enormous health impact of controlling or
eliminating conditions with a combined
disease burden that exceeds malaria or
tuberculosis, because the neglected tropi-
cal diseases also contribute to poverty,
reducing this disease burden would help
reduce poverty and therefore help achieve
the Millennium Development Goals
[38]. Neglected tropical disease control
and elimination would also help stabilize
and build nations, reduce civil strife and
international tensions, and contribute to
world peace [5,38]. Control of neglected
infections of poverty would eliminate an
important group of health disparities in
the US and Europe [6], while simulta-
neously providing a vehicle by which
nations such as India and China would
attain new status as global leaders.
Scientific and technical cooperation
between nuclear weapons states should
also be enhanced in order to improve
sanitation and water quality through
collaborative ventures in engineering and
urban planning, and to promote R&D for
new drugs and vaccines to combat
neglected tropical diseases [39,40]. Similar
‘‘vaccine diplomacy’’ efforts between the
US and Soviet Union during the Cold
War led to the successful development,
testing, and distribution of the oral polio
vaccine and the smallpox vaccine [41,42]
Greater efforts are needed to engage
leaders of the nuclear weapons states in a
frank dialogue about reallocation of re-
sources toward public health and scientific
pursuits for neglected tropical disease
R&D and control. Several possibilities
exist for such engagement. Conferences
are held every five years to review the
operation of the nuclear nonprofileration
treaty [43], and time should be set aside at
these meetings for purposes of disease
control and biomedical research. In 2009,
the first BRIC (Brazil, Russia, India,
China) summit took place in Russia [44],
and in the future this vehicle could also be
used to establish a meaningful dialogue on
neglected diseases. In the coming decade,
engaging the nuclear powers on neglected
disease R&D and global implementation
efforts would help to achieve Millennium
Development Goals and would represent a
significant diplomatic victory for the
world.
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